Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness, predictive response factors, and safety of anti-tumor necrosis factor (TNF) therapies in anti-TNF-naive rheumatoid arthritis.
Fernández-Nebro A, Irigoyen MV, Ureña I, Belmonte-López MA, Coret V, Jiménez-Núñez FG, Díaz-Cordovés G, López-Lasanta MA, Ponce A, Rodríguez-Pérez M, Calero E, González-Santos P. Fernández-Nebro A, et al. J Rheumatol. 2007 Dec;34(12):2334-42. Epub 2007 Nov 1. J Rheumatol. 2007. PMID: 17985409 Clinical Trial.
Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs in rheumatoid arthritis: results of the GO-MORE study in Spain.
Alonso A, González CM, Ballina J, García Vivar ML, Gómez-Reino JJ, Marenco JL, Fernández-Nebro A, Ordás C, Cea-Calvo L, Arteaga MJ, Sanmartí R. Alonso A, et al. Reumatol Clin. 2015 May-Jun;11(3):144-50. doi: 10.1016/j.reuma.2014.05.002. Epub 2014 Jul 10. Reumatol Clin. 2015. PMID: 25022442 Free article. Clinical Trial.
A genome-wide association study identifies SLC8A3 as a susceptibility locus for ACPA-positive rheumatoid arthritis.
Julià A, González I, Fernández-Nebro A, Blanco F, Rodriguez L, González A, Cañete JD, Maymó J, Alperi-López M, Olivé A, Corominas H, Martínez-Taboada V, Erra A, Sánchez-Fernández S, Alonso A, Lopez-Lasanta M, Tortosa R, Codó L, Gelpi JL, García-Montero AC, Bertranpetit J, Absher D, Bridges SL Jr, Myers RM, Tornero J, Marsal S. Julià A, et al. Rheumatology (Oxford). 2016 Jun;55(6):1106-11. doi: 10.1093/rheumatology/kew035. Epub 2016 Mar 15. Rheumatology (Oxford). 2016. PMID: 26983453 Free article.
Non-anti-TNF biologic agents are associated with slower worsening of interstitial lung disease secondary to rheumatoid arthritis.
Mena-Vázquez N, Godoy-Navarrete FJ, Manrique-Arija S, Aguilar-Hurtado MC, Romero-Barco CM, Ureña-Garnica I, Espildora F, Añón-Oñate I, Pérez-Albaladejo L, Gomez-Cano C, Jimenez-Núñez FG, Padin-Martín MI, Fernández-Nebro A. Mena-Vázquez N, et al. Clin Rheumatol. 2021 Jan;40(1):133-142. doi: 10.1007/s10067-020-05227-9. Epub 2020 Jun 16. Clin Rheumatol. 2021. PMID: 32557255
208 results